HAE
Haemonetics Corp.

636
Mkt Cap
$3.75B
Volume
336,914.00
52W High
$87.32
52W Low
$47.32
PE Ratio
23.38
HAE Fundamentals
Price
$80.15
Prev Close
$80.98
Open
$81.08
50D MA
$72.07
Beta
0.68
Avg. Volume
1.22M
EPS (Annual)
$3.31
P/B
4.41
Rev/Employee
$450,156.80
Loading...
Loading...
News
all
press releases
Haemonetics Corporation (NYSE:HAE) Given Consensus Rating of "Moderate Buy" by Brokerages
Haemonetics Corporation (NYSE:HAE - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are presently covering the stock, MarketBeat Ratings reports...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Fort Washington Investment Advisors Inc. OH Has $34.43 Million Stock Holdings in Haemonetics Corporation $HAE
Fort Washington Investment Advisors Inc. OH boosted its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 36.2% in the 3rd quarter, according to its most recent filing with the SEC. The...
MarketBeat·2d ago
News Placeholder
Haemonetics Corporation $HAE Shares Sold by Boston Trust Walden Corp
Boston Trust Walden Corp lessened its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 12.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange...
MarketBeat·2d ago
News Placeholder
Harbor Capital Advisors Inc. Purchases 14,226 Shares of Haemonetics Corporation $HAE
Harbor Capital Advisors Inc. boosted its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 49.7% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·6d ago
News Placeholder
Assenagon Asset Management S.A. Invests $8.56 Million in Haemonetics Corporation $HAE
Assenagon Asset Management S.A. bought a new position in shares of Haemonetics Corporation (NYSE:HAE - Free Report) in the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·11d ago
News Placeholder
Here's Why Haemonetics (HAE) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·13d ago
News Placeholder
Haemonetics (NYSE:HAE) Price Target Raised to $90.00
Mizuho upped their target price on Haemonetics from $75.00 to $90.00 and gave the company an "outperform" rating in a research report on Wednesday...
MarketBeat·15d ago
News Placeholder
Here's Why Haemonetics (HAE) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·17d ago
News Placeholder
Haemonetics (NYSE:HAE) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of Haemonetics from a "buy" rating to a "hold" rating in a research note on Sunday...
MarketBeat·18d ago
News Placeholder
Haemonetics (NYSE:HAE) Price Target Raised to $74.00 at JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted their target price on Haemonetics from $62.00 to $74.00 and gave the company a "neutral" rating in a research note on Friday...
MarketBeat·19d ago
<
1
2
...
>

Latest HAE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.